688606 奥泰生物
2024/09 - 九个月
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资22,013--0000
投资性房地产13,436-1.99%13,7099,33500
固定资产488,55996.45%248,698250,46698,62255,190
在建工程428,629-12.21%488,25442,29982,37411,620
无形资产108,689-1.58%110,43493,02728,11928,790
商誉0--0000
其他非流动资产80,693-13.71%93,514110,521131,05230,330
1,142,01919.63%954,610505,648340,166125,930

流动资产
货币资金1,201,122-8.84%1,317,5531,981,8432,179,315285,639
应收账款109,7978.85%100,870138,663208,199163,435
存货152,694-19.04%188,595193,660383,841123,726
其他流动资产1,559,0310.30%1,554,4311,875,009896,824452,379
3,022,645-4.39%3,161,4484,189,1743,668,1781,025,179

流动负债
短期借款0--0000
应付票据0--0000
应付帐款100,61329.64%77,609171,172360,65162,004
其他流动负债173,681-11.64%196,554339,580353,553116,441
274,2950.05%274,163510,753714,204178,445
流动资产净值2,748,351-4.81%2,887,2853,678,4222,953,974846,734
资产总额减流动负债3,890,3701.26%3,841,8954,184,0703,294,140972,664

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债6,436-37.74%10,33713,44320,5030
6,436-37.74%10,33713,44320,5030

总权益
    实收股本79,2810.00%79,28153,90453,90440,404
    储备项目3,800,3241.40%3,747,9684,112,3233,219,733932,260
股东权益3,879,6041.37%3,827,2494,166,2273,273,637972,664
非控股权益4,3290.46%4,3094,40000